Skip to main content

Asure (NASDAQ: ASUR) Trading at Discount Relative to HCM Industry Peers

The global human capital management (HCM) industry is enjoying favorable economic conditions that have been beneficial across the board for companies in the space. At a time when businesses big and small are looking to streamline operations, cut costs, and ensure compliance with a rapidly changing labor environment which includes more legislation that many small business owners must comply with, HCM service providers have seized the opportunity to offer solutions goals for their clients.

According to Fortune Business Insights, the global HCM market was valued at $28.86 billion in 2023 and is estimated to grow from $31.34 billion in 2024 to $63.14 billion by 2032. This projects a compound annual growth rate (CAGR) of 9.1% between 2024 and 2032, highlighting further opportunities ahead for HCM providers.

Asure Software (NASDAQ: ASUR) is an emerging HCM provider in an industry that has a very large TAM and has produced strong financial results for the last few years. Asure appears to be currently trading at a discounted valuation relative to its larger more well-known industry peers.

Looking Into Asure’s Recent Results and Guidance

The Texas-based company reported Q1 2024 results on May 2nd, which showed revenue of $30.7 million, which represented year-over-year growth of 10% (excluding ERTC, a one-time COVID era tax credit program). Management estimates total revenue to be between $125 million and $129 million for the full year 2024, on an adjusted EBITDA range of $25 million to $27 million (EBITDA margins of 20% to 21%). If we exclude ERTC from 2023 revenues this implies growth of 25% for 2024 based on management’s guidance for 2024. The compares for 2024 on a year over year basis in the first few quarters are tough, but these will ease as we enter the second half and especially once we get to Q4 2024. The growth rates will become much more appealing, and investors will start to take notice of this thus we think the stock will respond positively.

HCM Industry Valuation Comparison

In their Q1 2024 investor presentation, Asure broke down its valuation position compared to some of its industry peers: Paycor (NASDAQ: PYCR), ADP (NASDAQ: ADP), Paycom (NYSE: PAYC), Paylocity (NASDAQ: PCTY) and Paychex (NASDAQ: PAYX). From an enterprise value-to-revenue standpoint, Asure trades at 1.3x, compared to an average of 5.7x from its listed peers.

HCM Valuation; Source: Asure
HCM Valuation; Source: Asure

With an EV/revenue multiple even at the next lowest target (Paycor’s 4.2x) the implied share price for Asure stands at $20 per share. On the high end, Asure’s implied share price would be $37 if its EV/revenue multiple matched Paychex’s 7.8x. This provides a clear demonstration of Asure’s valuation state relative to some of the major peers in the HCM industry.

Overall, Asure Software continues to fly under the radar as a relatively undiscovered gem in the appealing HCM services industry. The company is growing its core business at a strong rates and management estimates for 2024 imply 25% plus growth (excluding ERTC revenues from 2023). Given Asure’s low EV/revenue valuation metric the stock looks to be much more enticing than its larger rivals. For now, Asure waits for the recognition it so richly deserves for the impressive and sustained growth its core HCM business has sustained and is forecasted to continue. For investors looking for bargains and underpriced opportunities, Asure appears to be a great place to do some further investigating.

Disclaimer:

Spotlight Growth is compensated, either directly or via a third party, to provide investor relations services for its clients. Spotlight Growth creates exposure for companies through a customized marketing strategy, including design of promotional material, the drafting and editing of press releases and media placement.

All information on featured companies is provided by the companies profiled, or is available from public sources. Spotlight Growth and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. The information contained herein is based on external sources that Spotlight Growth believes to be reliable, but its accuracy is not guaranteed. Spotlight Growth may create reports and content that has been compensated by a company or third-parties, or for purposes of self-marketing. Spotlight Growth was compensated four thousand dollars cash by Asure Software for the creation and dissemination of this content by the company.

This material does not represent a solicitation to buy or sell any securities. Certain statements contained herein constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may include, without limitation, statements with respect to the Company’s plans and objectives, projections, expectations and intentions. These forward-looking statements are based on current expectations, estimates and projections about the Company’s industry, management’s beliefs and certain assumptions made by management.

The above communication, the attachments and external Internet links provided are intended for informational purposes only and are not to be interpreted by the recipient as a solicitation to participate in securities offerings. Investments referenced may not be suitable for all investors and may not be permissible in certain jurisdictions.

Spotlight Growth and its affiliates, officers, directors, and employees may have bought or sold or may buy or sell shares in the companies discussed herein, which may be acquired prior, during or after the publication of these marketing materials. Spotlight Growth, its affiliates, officers, directors, and employees may sell the stock of said companies at any time and may profit in the event those shares rise in value. For more information on our disclosures, please visit: http://spotlightgrowth.com/disclosures/

The post Asure (NASDAQ: ASUR) Trading at Discount Relative to HCM Industry Peers appeared first on Spotlight Growth.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.